TY - JOUR
T1 - The association between perinatal factors and cardiometabolic risk factors in children and adolescents with overweight or obesity: A retrospective two-cohort study
AU - Prinz, N
AU - Putri, RR
AU - Reinehr, T
AU - Danielsson, P
AU - Weghuber, Daniel
AU - Norman, M
AU - Rochow, Niels
AU - Marcus, C
AU - Holl, RW
AU - Hagman, E
N1 - Weghuber: Department of Pediatrics, Paracelsus Private Medical School, Salzburg, Austria;
Obesity Research Unit, Paracelsus Private Medical School, Salzburg, Austria; Rochow: Department of Pediatrics, Paracelsus Medical University, Nuremberg, Germany
PY - 2023/1
Y1 - 2023/1
N2 - BackgroundChildren with obesity have an increased risk of cardiometabolic risk factors, but not all children carry a similar risk. Perinatal factors, i.e., gestational age (GA) and birth weight for GA, may affect the risk for metabolic complications. However, there are conflicting data whether the association between birth size and cardiometabolic risk factors is independent among children with obesity. Moreover, differential effects of GA and birth weight for GA on cardiometabolic risk factors in pediatric obesity are still unexplored. We aimed to investigate the association between birth weight for GA and cardiometabolic risk factors in children and adolescents with overweight or obesity and to assess whether the association is modified by prematurity. Methods and findingsWe conducted a retrospective study of 2 cohorts, using data from the world's 2 largest registers of pediatric obesity treatment-The Swedish childhood obesity treatment register (BORIS) and The Adiposity Patients Registry (APV) (1991 to 2020). Included were individuals with overweight or obesity between 2 to 18 years of age who had data of birth characteristics and cardiometabolic parameters. Birth data was collected as exposure variable and the first reported cardiometabolic parameters during pediatric obesity treatment as the main outcome. The median (Q1, Q3) age at the outcome measurement was 11.8 (9.4, 14.0) years. The main outcomes were hypertensive blood pressure (BP), impaired fasting glucose, elevated glycated hemoglobin (HbA1c), elevated total cholesterol, elevated low-density lipoprotein (LDL) cholesterol, elevated triglycerides, decreased high-density lipoprotein (HDL) cholesterol, and elevated transaminases. With logistic regression, we calculated the odds ratio (OR) and its 95% confidence interval (CI) for each cardiometabolic parameter. All the analyses were adjusted for sex, age, degree of obesity, migratory background, and register source.In total, 42,760 (51.9% females) individuals were included. Small for GA (SGA) was prevalent in 10.4%, appropriate for GA (AGA) in 72.4%, and large for GA (LGA) in 17.2%. Most individuals (92.5%) were born full-term, 7.5% were born preterm. Median (Q1, Q3) body mass index standard deviation score at follow-up was 2.74 (2.40, 3.11) units. Compared with AGA, children born SGA were more likely to have hypertensive BP (OR = 1.20 [95% CI 1.12 to 1.29], p < 0.001), elevated HbA1c (1.33 [1.06 to 1.66], p = 0.03), and elevated transaminases (1.21 [1.10 to 1.33], p < 0.001) as well as low HDL (1.19 [1.09 to 1.31], p < 0.001). On the contrary, individuals born LGA had lower odds for hypertensive BP (0.88 [0.83 to 0.94], p < 0.001), elevated HbA1c (0.81 [0.67 to 0.97], p < 0.001), and elevated transaminases (0.88 [0.81 to 0.94], p < 0.001). Preterm birth altered some of the associations between SGA and outcomes, e.g., by increasing the odds for hypertensive BP and by diminishing the odds for elevated transaminases. Potential selection bias due to occasionally missing data could not be excluded. ConclusionsAmong children and adolescents with overweight/obesity, individuals born SGA are more likely to possess cardiometabolic risk factors compared to their counterparts born AGA. Targeted screening and treatment of obesity-related comorbidities should therefore be considered in this high-risk group of individuals.Author summary Why was this study done? Pediatric obesity and born small for gestational age (SGA) are 2 risk factors for cardiometabolic disorders.There are conflicting data regarding whether the association between birth size and cardiometabolic risk factors in childhood is independent or mediated by adiposity.Differential effects of SGA and preterm birth on cardiometabolic risk factors in pediatric obesity are unknown. What did the researchers do and find? Using data from the world's 2 largest registers of pediatric obesity treatment, we investigated the association between SGA and cardiometabolic risk factors among children with overweight or obesity and explored whether the association between SGA and cardiometabolic risk factors was modified by preterm birth.Compared with appropriate for gestational age (GA), children with overweight/obesity born SGA were, independent of sex, age, and degree of obesity, more likely to have elevated blood pressure, glycated hemoglobin (HbA1c), and transaminases as well as low high-density lipoprotein (HDL) cholesterol.Preterm birth modified some of the associations between SGA and outcomes, e.g., by increasing the odds for elevated blood pressure and by diminishing the odds for elevated transaminases. What do these findings mean? In pediatric obesity treatment, early screening and treatment of obesity-related comorbidities should be considered in children who are born SGA.
AB - BackgroundChildren with obesity have an increased risk of cardiometabolic risk factors, but not all children carry a similar risk. Perinatal factors, i.e., gestational age (GA) and birth weight for GA, may affect the risk for metabolic complications. However, there are conflicting data whether the association between birth size and cardiometabolic risk factors is independent among children with obesity. Moreover, differential effects of GA and birth weight for GA on cardiometabolic risk factors in pediatric obesity are still unexplored. We aimed to investigate the association between birth weight for GA and cardiometabolic risk factors in children and adolescents with overweight or obesity and to assess whether the association is modified by prematurity. Methods and findingsWe conducted a retrospective study of 2 cohorts, using data from the world's 2 largest registers of pediatric obesity treatment-The Swedish childhood obesity treatment register (BORIS) and The Adiposity Patients Registry (APV) (1991 to 2020). Included were individuals with overweight or obesity between 2 to 18 years of age who had data of birth characteristics and cardiometabolic parameters. Birth data was collected as exposure variable and the first reported cardiometabolic parameters during pediatric obesity treatment as the main outcome. The median (Q1, Q3) age at the outcome measurement was 11.8 (9.4, 14.0) years. The main outcomes were hypertensive blood pressure (BP), impaired fasting glucose, elevated glycated hemoglobin (HbA1c), elevated total cholesterol, elevated low-density lipoprotein (LDL) cholesterol, elevated triglycerides, decreased high-density lipoprotein (HDL) cholesterol, and elevated transaminases. With logistic regression, we calculated the odds ratio (OR) and its 95% confidence interval (CI) for each cardiometabolic parameter. All the analyses were adjusted for sex, age, degree of obesity, migratory background, and register source.In total, 42,760 (51.9% females) individuals were included. Small for GA (SGA) was prevalent in 10.4%, appropriate for GA (AGA) in 72.4%, and large for GA (LGA) in 17.2%. Most individuals (92.5%) were born full-term, 7.5% were born preterm. Median (Q1, Q3) body mass index standard deviation score at follow-up was 2.74 (2.40, 3.11) units. Compared with AGA, children born SGA were more likely to have hypertensive BP (OR = 1.20 [95% CI 1.12 to 1.29], p < 0.001), elevated HbA1c (1.33 [1.06 to 1.66], p = 0.03), and elevated transaminases (1.21 [1.10 to 1.33], p < 0.001) as well as low HDL (1.19 [1.09 to 1.31], p < 0.001). On the contrary, individuals born LGA had lower odds for hypertensive BP (0.88 [0.83 to 0.94], p < 0.001), elevated HbA1c (0.81 [0.67 to 0.97], p < 0.001), and elevated transaminases (0.88 [0.81 to 0.94], p < 0.001). Preterm birth altered some of the associations between SGA and outcomes, e.g., by increasing the odds for hypertensive BP and by diminishing the odds for elevated transaminases. Potential selection bias due to occasionally missing data could not be excluded. ConclusionsAmong children and adolescents with overweight/obesity, individuals born SGA are more likely to possess cardiometabolic risk factors compared to their counterparts born AGA. Targeted screening and treatment of obesity-related comorbidities should therefore be considered in this high-risk group of individuals.Author summary Why was this study done? Pediatric obesity and born small for gestational age (SGA) are 2 risk factors for cardiometabolic disorders.There are conflicting data regarding whether the association between birth size and cardiometabolic risk factors in childhood is independent or mediated by adiposity.Differential effects of SGA and preterm birth on cardiometabolic risk factors in pediatric obesity are unknown. What did the researchers do and find? Using data from the world's 2 largest registers of pediatric obesity treatment, we investigated the association between SGA and cardiometabolic risk factors among children with overweight or obesity and explored whether the association between SGA and cardiometabolic risk factors was modified by preterm birth.Compared with appropriate for gestational age (GA), children with overweight/obesity born SGA were, independent of sex, age, and degree of obesity, more likely to have elevated blood pressure, glycated hemoglobin (HbA1c), and transaminases as well as low high-density lipoprotein (HDL) cholesterol.Preterm birth modified some of the associations between SGA and outcomes, e.g., by increasing the odds for elevated blood pressure and by diminishing the odds for elevated transaminases. What do these findings mean? In pediatric obesity treatment, early screening and treatment of obesity-related comorbidities should be considered in children who are born SGA.
KW - FATTY LIVER-DISEASE
KW - LOW-BIRTH-WEIGHT
KW - FOR-GESTATIONAL-AGE
KW - CARDIOVASCULAR RISK
KW - BLOOD-PRESSURE
KW - INSULIN-RESISTANCE
KW - GROWTH
KW - CHILDHOOD
KW - PREDICTORS
KW - INCREASES
U2 - 10.1371/journal.pmed.1004165
DO - 10.1371/journal.pmed.1004165
M3 - Original Article (Journal)
C2 - 36638094
SN - 1549-1277
VL - 20
SP - e1004165
JO - PLOS MEDICINE
JF - PLOS MEDICINE
IS - 1
M1 - e1004165
ER -